29 42

Cited 0 times in

Interim Guidelines on Antiviral Therapy for COVID-19

Authors
 Sun Bean Kim  ;  Kyungmin Huh  ;  Jung Yeon Heo  ;  Eun Jeong Joo  ;  Youn Jeong Kim  ;  Won Suk Choi  ;  Yae Jean Kim  ;  Yu Bin Seo  ;  Young Kyung Yoon  ;  Nam Su Ku  ;  Su Jin Jeong  ;  Sung Han Kim  ;  Kyong Ran Peck  ;  Joon Sup Yeom 
Citation
 INFECTION AND CHEMOTHERAPY, Vol.52(2) : 281-304, 2020-06 
Journal Title
 INFECTION AND CHEMOTHERAPY 
ISSN
 2093-2340 
Issue Date
2020-06
Keywords
Antiviral ; COVID-19 ; SARS-CoV-2 ; Treatment
Abstract
Since the first case was reported in Wuhan, Hubei Province, China on December 12, 2019, Coronavirus disease 2019 (COVID-19) has spread widely to other countries since January 2020. As of April 16, 2020, 10635 confirmed cases have been reported, with 230 deaths in Korea. COVID-19 patients may be asymptomatic or show various clinical manifestations, including acute symptoms such as fever, fatigue, sore throat; pneumonia presenting as acute respiratory distress syndrome; and multiple organ failure. As COVID-19 has such varied clinical manifestations and case fatality rates, no standard antiviral therapy regimen has been established other than supportive therapy. In the present guideline, we aim to introduce potentially helpful antiviral and other drug therapies based on in vivo and in vitro research and clinical experiences from many countries.
Files in This Item:
T202006007.pdf Download
DOI
10.3947/ic.2020.52.2.281
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Ku, Nam Su(구남수) ORCID logo https://orcid.org/0000-0002-9717-4327
Yeom, Joon Sup(염준섭) ORCID logo https://orcid.org/0000-0001-8940-7170
Jeong, Su Jin(정수진) ORCID logo https://orcid.org/0000-0003-4025-4542
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/181526
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links